Caradon Therapeutics, Inc.

CIK 2108983 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Caradon Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 3, 2026D0002108983-26-000001